The U.S. Food and Drug Administration (FDA) has announced several significant developments this week, spanning advancements ...

ALK (ALKB:DC / OMX: ALK B) today announced that the US Food and Drug Administration (FDA) has approved ALK's ODACTRA® tablet for use in young children with house dust mite (HDM) allergy. ODACTRA® is ...

Allergies are not fun, just ask anyone who has them. It might not be allergy season for lots of us, but it is for children.

Another reason why you may still be battling dust is having the wrong sized air purifier for the room. “If you're still ...

Spring brings warmer weather, but for allergy sufferers, it also means sneezing, wheezing and itchy eyes. Instead of enjoying ...

Signs your pet has allergies include scratching and biting their coat or skin, compulsive paw licking, excessive shedding, ...

Results from a Phase III study in pediatric patients demonstrated that Odactra reduced the total combined rhinitis score by 22% compared to placebo.

The Food and Drug Administration (FDA) has expanded the approval of Odactra® (house dust mite allergen tablet) to include the treatment of house dust mite ...

ALK announced that the U.S. FDA expanded its indication of Odactra for the treatment of house dust mite-induced allergic rhinitis, with or ...

The US Food and Drug Administration (FDA) has approved Odactra tablet for use in young children with house dust mite (HDM) ...

The FDA expanded the approval of a sublingual immunotherapy (SLIT; Odactra) for treating house dust mite allergies in young ...

ALK (ALKB:DC / OMX: ALK B) today announced that the US Food and Drug Administration (FDA) has approved ALK’s ODACTRA® tablet for use in young children with house dust mite (HDM) allergy. ODACTRA® is ...